Table 1 Socio-demographic and biomedical data
|  | All patients (N = 267) | |
|---|---|---|
Sex (females: n, %) | 93 (35%) | |
Age (in years; M, SD, range) | 52.8 ± 13.7 (18–80) | |
Age at transplantation (in years; M, SD, range) | 45.8 ± 14.7 (2–76) | |
Time since last transplantation (in years; M, SD, range) | 7.1 ± 6.2 (1–34) | |
Dialysis before transplantation (yes: n, %) | 238 (89.1%) | |
Immunosuppressive medication (n, %) | Tacrolimus | 180 (67.4%) |
Cyclosporine | 59 (22.1%) | |
Sirolimus | 22 (8.2%) | |
Everolimus | 6 (2.2%) | |
Number of renal transplantations (n, %) | 1 | 233 (87.3%) |
2 | 26 (9.7%) | |
3 | 8 (3.0%) | |
Number of IS trough levels (M, SD, range) | 9.6 ± 4.3 (4–37) | |
IS trough level variability (M, SD, range) | 21.3 ± 10.2 (2.7–56.1) | |
Percentage of sub-therapeutic IS trough levels (M, SD, range) | 42.3 ± 27.6 (0–100%) | |
Patient-reported non-adherence (n, %) | 89 (33%) | |